increased hepatocellular carcinoma incidence_Tg(Myl2-FGF19)1Dfre/?

http://metadb.riken.jp/0003331IFVBTgMyl2FGF191DfreTgMyl2FGF191Dfre

increased hepatocellular carcinoma incidence_Tg(Myl2-FGF19)1Dfre/?

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion 1, Dorothy M French
  http://metadb.riken.jp/db/mgi_rdf/MGI:3621047

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(Myl2-FGF19)1Dfre/?

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(Myl2-FGF19)1Dfre

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: FVB

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased hepatocellular carcinoma incidence
  http://purl.obolibrary.org/obo/MP_0003331

文献

http://purl.org/net/cito/citesAsAuthority

• Dorothy M. French, et.al., Targeting FGFR4 inhibits hepatocellular carcinoma in preclinical mouse models., PloS one, 2012, 7
  http://rdf.ncbi.nlm.nih.gov/pubmed/22615798
• Katrina. Nicholes, et.al., A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice., The American journal of pathology, 2002, 160
  http://rdf.ncbi.nlm.nih.gov/pubmed/12057932